famotidine has been researched along with Syndrome in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camerini, S | 1 |
| Cantarelli, A | 1 |
| Spotti, M | 1 |
| Nolli, M | 1 |
1 trial available for famotidine and Syndrome
| Article | Year |
|---|---|
[Comparison of the efficacy of famotidine and cimetidine in in prophylaxis of Mendelson's syndrome in elective surgery].
Topics: Cimetidine; Famotidine; Female; Humans; Male; Middle Aged; Pneumonia, Aspiration; Postoperative Comp | 1991 |